Epidermal growth factor, basic fibroblast growth factor and platelet-derived growth factor-bb can substitute for fetal bovine serum and compete with human platelet-rich plasma in the ex vivo expansion of mesenchymal stromal cells derived from adipose tissue

References

• Kolf CM, Cho E, Tuan RS. Mesenchymal stromal cells. Biology of adult stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res Ther. 2007;7:204–14.
   Google Scholar
• Bruder SP, Kurth AA, Shea M, Hayes WC, Jaiswal N, Kadiyala S. Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells. J Orthop Res. 1998;16:155–62.
   PubMed Web of Science ®Google Scholar
• De Kok I, Peter SJ, Archambault M, van den Bos C, Kadiyala S, Aukhil I, . Investigation of allogeneic mesenchymal stem cell-based alveolar bone formation: preliminary findings. Clin Oral Implants Res. 2003;14:481–9.
   PubMed Web of Science ®Google Scholar
• Wakitani S, Goto T, Pineda SJ, Young RG, Mansour JM, Caplan AI, . Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage. J Bone Joint Surg Am. 1994;76:579–92.
   PubMed Web of Science ®Google Scholar
• Awad HA, Boivin GP, Dressler MR, Smith FN, Young RG, Butler DL. Repair of patellar tendon injuries using a cell-collagen composite. J Orthop Res. 2003;21:420–31.
   PubMed Web of Science ®Google Scholar
• Murphy JM, Fink DJ, Hunziker EB, Burry FP. Stem cell therapy in a caprine model of osteoarthritis. Arthritis Rheum. 2003;48:3464–74.
   PubMed Web of Science ®Google Scholar
• Wakitani S, Saito T, Caplan AI. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve. 1995;18:1417–26.
   PubMed Web of Science ®Google Scholar
• Pittenger MF, Martin BJ. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res. 2004;95:9–20.
   PubMed Web of Science ®Google Scholar
• Kawada H, Fujita J, Kinjo K, Matsuzaki Y, Tsuma M, Miyatake H, . Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. Blood. 2004;104:3581–7.
   PubMed Web of Science ®Google Scholar
• Kopen GC, Prockop DJ, Phinney DG. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci USA. 1999;96:10711–6.
   PubMed Web of Science ®Google Scholar
• Woodbury D, Schwarz EJ, Prockop DJ, Black IB. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res. 2000;61:364–70.
   PubMed Web of Science ®Google Scholar
• Horwitz EM, Prockop DJ, Fitzpatrick LA, Koo WW, Gordon PL, Neel M, . Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med. 1999;5:309–13.
   PubMed Web of Science ®Google Scholar
• Horwitz EM, Gordon PL, Koo WK, Marx JC, Neel MD, McNall RY, . Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci USA. 2002;99:8932–7.
   PubMed Web of Science ®Google Scholar
• Le Blanc K, Rasmusson I, Sundberg B, Götherström C, Hassan M, Uzunel M, . Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet. 2004;363:1439–41.
   PubMed Web of Science ®Google Scholar
• Koc ON, Gerson SL, Cooper BW, Dyhouse SM, Haynesworth SE, Caplan AI, . Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol. 2000;18:307–16.
   PubMed Web of Science ®Google Scholar
• Multicenter Clinical Trial for the Evaluation on Mesenchymal Stem Cells from Adipose Tissue in Patient with Chronic Graft versus Host Disease (CMM/EICH/2008). Available at: http://clinicaltrials.gov
   Google Scholar
• Treatment of refractory (acute or chronic) graft versus host disease by the infusion of expanded in vitro allogenic mesenchymal stem cell. Available at: http://clinicaltrials.gov
   Google Scholar
• Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood. 2005;105: 1815–22.
   PubMed Web of Science ®Google Scholar
• Di Nicola M, Carlo Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, . Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or non-specific mitogenic stimuli. Blood. 2002;99:3838–43.
   PubMed Web of Science ®Google Scholar
• Krampera M, Glennie S, Dyson J, Cott D, Laylor R, Simpson E, . Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood. 2003;101:3722–9.
   PubMed Web of Science ®Google Scholar
• Doerr HW, Cinatl J, Sturmer M, Rabenau HF. Prions and orthopedic surgery. Infection. 2003;31:163–71.
   PubMed Web of Science ®Google Scholar
• Spees JL, Gregory CA, Singh H, Tucker HA, Peister A, Lynch PJ, . Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy. Mol Ther. 2004;9:747–56.
   PubMed Web of Science ®Google Scholar
• Doucet C, Ernou I, Zhang Y, Llense JR, Begot L, Holy X, . Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy application. J Cell Physiol. 2005;205:228–36.
   PubMed Web of Science ®Google Scholar
• Kocaoemer A, Kern S, Uter H, Bieback K. Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. Stem Cells. 2007;25: 1270–8.
   PubMed Web of Science ®Google Scholar
• Battula VL, Bareiss PM, Treml S, Conrad S, Albert I, Hojak S, . Human placenta and bone marrow derived MSC cultured in serum-free, b-FGF-containing medium express cell surface frizzled-9 and SSEA-4 and give rise to multilineage differentiation. Differentiation. 2007;75:279–91.
   PubMed Web of Science ®Google Scholar
• Krampera M, Pasini A, Rigo A, Scupoli MT, Tecchio C, Malpeli G, . HB-EGF/HER-1 signaling in bone marrow mesenchymal stem cells: induced cell expansion and reversibly preventing multilineage differentiation. Blood. 2005;106:59–66.
   PubMed Web of Science ®Google Scholar
• Longobardi L, O'Rear L, Aakula S, Johnstone B, Shimer K, Chytil A, . Effect of IGF-I in the condrogenesis of bone marrow mesenchymal stem cells in the presence or absence of TGF signalling. J Bone Min Res. 2006;21:626–36.
   PubMed Web of Science ®Google Scholar
• Solchaga LA, Penick K, Porter JD, Goldberg VM, Caplan AI, Welter JF. FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrow-derived mesenchymal stem cells. J Cell Physiol. 2005;203:398–409.
   PubMed Web of Science ®Google Scholar
• Tamana K, Fan VH, Griffith LG, Blair HC, Wells A. Epidermal growth factor as a candidate for ex vivo expansion of bone marrow-derived mesenchymal stem cells. Stem Cells. 2006; 24:686–95.
   PubMedGoogle Scholar
• Thomas T, Gori F, Spelberg TC, Khosla S, Riggs B, Conover CA. Response of biopotential human marrow stromal cells to insulin-like growth factors: effect on binding protein production, proliferation, and commitment to osteoblasts and adipocytes. Endocrinology. 1999;140:5036–44.
   PubMed Web of Science ®Google Scholar
• Yangxin L, XiYong Y, ShuGuang L, XiaoHong L, Saidan Z, Yao-Hua S. Insulin-like growth factor 1 enhances the migratory capacity of mesenchymal stem cells. Biochem Biophys Res Comm. 2007;356:780–4.
   PubMedGoogle Scholar
• Stenderup K, Justuesen J, Clausen C, Kassem M. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone. 2003;3: 919–26.
   Google Scholar
• McIntyre A, Bjornson BH. Human bone marrow stromal cell colonies: response to hydrocortisone and dependence on platelet-derived growth factor. Exp Hematol. 1986;14:833–9.
   PubMedGoogle Scholar
• Keshavarz E, Hoare M, Dunnill P. Biochemical engineering aspects of cell disruption. Verrall MS, Hudson MJ. Separations for Biotechnology. Chichester: Ellis Horwood Series; 1987;34:62–79.
   Google Scholar
• Freshney RI. Culture of Animal Cells. A Manual of Basic technique. 5th. Wiley-Liss Publication. New Jersey. 2005.
   Google Scholar
• Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini FC, Krause DS, . Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315–7.
   PubMed Web of Science ®Google Scholar
• Storms RW, Trujillo AP, Springer JB, Shah L, Colvin OM, Ludeman SM, . Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity. Proc Natl Acad Sci USA. 1999;96:9118–23.
   PubMed Web of Science ®Google Scholar
• Storms RW, Green PD, Safford KM, Niedzwiecki D, Cogle CR, Colvin OM, . Distinct hematopoietic progenitor compartments are delineated by the expression of aldehyde dehydrogenase and CD34. Blood. 2005;106:95–102.
   PubMed Web of Science ®Google Scholar
• Christ O, Lucke K, Leung K, Hamilton M, Eaves A, Smith C, . Improved purification of hematopoietic stem cells based on their elevated aldehyde dehydrogenase activity. Haematologica. 2007;92:1165–72.
   PubMedGoogle Scholar
• Sahovic EA, Colvin M, Hilton J, Ogawa M. Role for aldehyde dehydrogenase in survival of progenitors for murine blast cell colonies after treatment with 4-hydroperoxycyclophosphamide in vitro. Cancer Res. 1998;48:1223–6.
   Google Scholar
• Gruber R, Karreth F, Kandler B, Fuerst G, Rot A, Fisher MB, . Platelet-released supernatants increase migration and proliferation, and decrease osteogenic differentiation of bone marrow derived-mesenchymal progenitor cells under in vitro conditions. Platelets. 2004;15:29–35.
   PubMed Web of Science ®Google Scholar
• Mitchell JB, McIntosh K, Zvonic S, Garrett S, Floyd E, Kloster A, . Immunophenotype of human adipose-derived cells: temporal changes in stromal-associated and stem cell-associated markers. Stem Cells. 2006;24:376–85.
   PubMed Web of Science ®Google Scholar
• Im GI, Shin YW, Lee KB. Do adipose tissue-derived mesenchymal stem cells have the same osteogenic and chondrogenic potential as bone marrow-derived cells. Osteoarth Cart. 2005;13:845–53.
   PubMed Web of Science ®Google Scholar
• Hui JH, Li L, Teo YH, Ouyang HW, Lee EH. Comparative study of the ability of mesenchymal stem cells derived from bone marrow, periosteum and adipose tissue in treatment of partial growth arrest in rabbit. Tissue Eng. 2005;11:904–12.
   PubMedGoogle Scholar